Our latest research work, in collaboration with scientists at the Centre for Nanotechnology in Medicine of The University of Manchester, has been published in Science Translational Medicine.

The research identified two specific periods during which the blood-brain barrier becomes temporarily disrupted, allowing liposomes to target the glioblastoma resection marginal zone tissue more effectively, leading to significant survival in different preclinical models of this difficult-to-treat cancer.

Link to ICN2 and The University of Manchester press releases.